LC–MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1)

  • Yazhong Liu
  • , Fang Zhou
  • , Hua Sang
  • , Hui Ye
  • , Qianying Chen
  • , Lan Yao
  • , Ping Ni
  • , Guangji Wang
  • , Jingwei Zhang

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Lysine-MCC-DM1, MCC-DM1 and DM1 are potential catabolites of trastuzumab emtansine (T-DM1). A convenient liquid chromatography-tandem mass spectrometry (LC–MS/MS) method was developed and validated to detect these catabolites simultaneously in in vitro investigations for the first time. Protein precipitation was utilized to prepare the samples. Chromatographic separation was achieved on a Phenomenex Kinetex C18 column (100 × 2.1 mm, 2.6 μm) with mobile-phase gradient elution. The calibration curves of each analyte ranging from 1 to 100 nM showed good linearity (r2 > 0.995). The method was validated successfully and applied to the intracellular catabolism and regulation of T-DM1.

Original languageEnglish
Pages (from-to)170-177
Number of pages8
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume137
DOIs
StatePublished - 15 Apr 2017
Externally publishedYes

Keywords

  • Antibody-drug conjugate
  • Catabolites
  • LC–MS/MS
  • T-DM1

Fingerprint

Dive into the research topics of 'LC–MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1)'. Together they form a unique fingerprint.

Cite this